河北医学
河北醫學
하북의학
HEBEI MEDICINE
2014年
6期
921-924
,共4页
肠梗阻手术%参附注射液%白细胞介素-2%TNF-α%T淋巴细胞亚群
腸梗阻手術%參附註射液%白細胞介素-2%TNF-α%T淋巴細胞亞群
장경조수술%삼부주사액%백세포개소-2%TNF-α%T림파세포아군
Intestinal obstruction surgery%Shenfu injection%Interleukin -2%TNF-α%T lym-phocyte subsets
目的:研究肠梗阻手术后用参附注射液治疗对病患白细胞介素-2(IL-2),TNF-α以及T淋巴细胞亚群( T lymphocyte subsets ,TLS)的影响。方法:从2012年2月到2013年2月,我院有96例病患行肠梗阻手术。以数字法随机分成观察组(48例)和对照组(48例)。对照组实施常规治疗,观察组则主要以参附注射液进行治疗。对比两组肠鸣音的恢复时间以及肛门排气时间,治疗前后TLS情况以及治疗前后IL-2及TNF-α情况。结果:观察组肠鸣音的恢复时间为61.1±14.4h,肛门排气时间为85.3±16.4h,显著少于对照组的73.7±13.4h,85.3±16.4h;观察组治疗之后CD4为30.90±7.18, CD4/CD8为1.11±0.24,均显著高于治疗之前的25.13±7.45,0.75±0.28,以及高于对照组治疗之后的27.11±4.81,0.72±0.18;观察组治疗之后CD8为30.42±5.61显著低于对照组治疗之后的39.38±6.77;观察组治疗之后IL-2水平为60.11±19.91 mg/L,显著高于治疗之前的35.68±21.33 mg/L,以及对照组治疗之后的44.08±17.76 mg/L。观察组治疗之后TNF-α水平显著低于治疗之前的56.75±6.20μg/L,以及对照组治疗之后的42.63±7.96μg/L;差异均有统计学意义(均P<0.05)。结论:肠梗阻术后以参附注射液实施治疗在明显促进病患恢复的同时,还可增加IL-2和CD4以及CD4/CD8,降低CD8和TNF-α水平,具有显著疗效,值得临床推荐。
目的:研究腸梗阻手術後用參附註射液治療對病患白細胞介素-2(IL-2),TNF-α以及T淋巴細胞亞群( T lymphocyte subsets ,TLS)的影響。方法:從2012年2月到2013年2月,我院有96例病患行腸梗阻手術。以數字法隨機分成觀察組(48例)和對照組(48例)。對照組實施常規治療,觀察組則主要以參附註射液進行治療。對比兩組腸鳴音的恢複時間以及肛門排氣時間,治療前後TLS情況以及治療前後IL-2及TNF-α情況。結果:觀察組腸鳴音的恢複時間為61.1±14.4h,肛門排氣時間為85.3±16.4h,顯著少于對照組的73.7±13.4h,85.3±16.4h;觀察組治療之後CD4為30.90±7.18, CD4/CD8為1.11±0.24,均顯著高于治療之前的25.13±7.45,0.75±0.28,以及高于對照組治療之後的27.11±4.81,0.72±0.18;觀察組治療之後CD8為30.42±5.61顯著低于對照組治療之後的39.38±6.77;觀察組治療之後IL-2水平為60.11±19.91 mg/L,顯著高于治療之前的35.68±21.33 mg/L,以及對照組治療之後的44.08±17.76 mg/L。觀察組治療之後TNF-α水平顯著低于治療之前的56.75±6.20μg/L,以及對照組治療之後的42.63±7.96μg/L;差異均有統計學意義(均P<0.05)。結論:腸梗阻術後以參附註射液實施治療在明顯促進病患恢複的同時,還可增加IL-2和CD4以及CD4/CD8,降低CD8和TNF-α水平,具有顯著療效,值得臨床推薦。
목적:연구장경조수술후용삼부주사액치료대병환백세포개소-2(IL-2),TNF-α이급T림파세포아군( T lymphocyte subsets ,TLS)적영향。방법:종2012년2월도2013년2월,아원유96례병환행장경조수술。이수자법수궤분성관찰조(48례)화대조조(48례)。대조조실시상규치료,관찰조칙주요이삼부주사액진행치료。대비량조장명음적회복시간이급항문배기시간,치료전후TLS정황이급치료전후IL-2급TNF-α정황。결과:관찰조장명음적회복시간위61.1±14.4h,항문배기시간위85.3±16.4h,현저소우대조조적73.7±13.4h,85.3±16.4h;관찰조치료지후CD4위30.90±7.18, CD4/CD8위1.11±0.24,균현저고우치료지전적25.13±7.45,0.75±0.28,이급고우대조조치료지후적27.11±4.81,0.72±0.18;관찰조치료지후CD8위30.42±5.61현저저우대조조치료지후적39.38±6.77;관찰조치료지후IL-2수평위60.11±19.91 mg/L,현저고우치료지전적35.68±21.33 mg/L,이급대조조치료지후적44.08±17.76 mg/L。관찰조치료지후TNF-α수평현저저우치료지전적56.75±6.20μg/L,이급대조조치료지후적42.63±7.96μg/L;차이균유통계학의의(균P<0.05)。결론:장경조술후이삼부주사액실시치료재명현촉진병환회복적동시,환가증가IL-2화CD4이급CD4/CD8,강저CD8화TNF-α수평,구유현저료효,치득림상추천。
Objective:To study the influence of interleukin -2, TNF-α and T lymphocyte subsets of the patients after intestinal obstruction surgery treated with Shenfu injection .Method:From February 2012 to February 2013, a total of 96 cases of patients needed intestinal obstruction surgery in our hospital .They were divided into the observation group (48 cases) and the control group (48 cases) according to digital random-ly.The control group was treated with conventional treatment , while the observation group was mainly treated with Shenfu injection , compared two groups of the recovery time of bowel sound , anal exhaust time and TLS , and IL-2 and TNF-αlevel before and after treatment .Result: The observation group ’ s recovery time of bowel sound was 61.1 ±14.4 hours, anal exhaust time was 85.3 ±16.4 hours, which were significantly less than those in control group of 73.7 ±13.4 hours, 85.3 ±16.4 hours; the observation group ’ s CD4 after treatment was 30.90 ±7.18, CD4/CD8 was 1.11 ±0.24, which were significantly higher than before treat-ment of 25.13 ±7.45, 0.75 ±0.28, and the control group after treatment of 27.11 ±4.81, 0.72 ±0.18;the observation group ’ s CD8 after treatment was 30.42 ±5.61 which were significantly lower than the control group after treatment of 39.38 ±6.77;the observation group ’ s IL-2 level after treatment was 60.11 ±19.91 mg /L, which was significantly higher than before treatment of 35.68 ±21.33 mg /L, and the control group after treatment of 44.08 ±17.76 mg /L.The observation group’s TNF-αlevel was 31.76±7.16μg/L,which was significantly lower than before treatment of 56.75 ±6.20μg /L, and the control group after treatment of 42.63 ±7.96μg /L;all the differences were statistically significant (all P <0.05).Conclusion: Patients with intestinal obstruction surgery using Shenfu injection can significantly promote the recovery , while also increase IL-2 and CD4, CD4/CD8, and reduce CD8, TNF-α, It's effective to,it is worthy of clinical rec-ommended.